The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 117K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adler, A. J.
Right arrow Articles by Pardoll, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adler, A. J.
Right arrow Articles by Pardoll, D. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1998/5/1555/ $5.00
The Journal of Experimental Medicine, Volume 187, Number 10, May 18, 1998 1555-1564


Articles

CD4+ T Cell Tolerance to Parenchymal Self-Antigens Requires Presentation by Bone Marrow–derived Antigen-presenting Cells

Adam J. Adler*, David W. Marsh*, Gregory S. Yochum*, James L. Guzzo*, Ankesh Nigam{ddagger}, William G. Nelson*, and Drew M. Pardoll*

From the * Department of Oncology and the {ddagger} Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205

T cell tolerance to parenchymal self-antigens is thought to be induced by encounter of the T cell with its cognate peptide–major histocompatibility complex (MHC) ligand expressed on the parenchymal cell, which lacks appropriate costimulatory function. We have used a model system in which naive T cell receptor (TCR) transgenic hemagglutinin (HA)-specific CD4+ T cells are adoptively transferred into mice expressing HA as a self-antigen on parenchymal cells. After transfer, HA-specific T cells develop a phenotype indicative of TCR engagement and are rendered functionally tolerant. However, T cell tolerance is not induced by peptide–MHC complexes expressed on parenchymal cells. Rather, tolerance induction requires that HA is presented by bone marrow (BM)–derived cells. These results indicate that tolerance induction to parenchymal self-antigens requires transfer to a BM-derived antigen-presenting cell that presents it to T cells in a tolerogenic fashion.

Key Words: peripheral tolerance • CD4+ T cells • antigen-presenting cells • adoptive T cell transfer • transgenic mice


Address correspondence to Drew Pardoll, 720 Rutland Ave., Ross 364, Baltimore, MD 21205. Phone: 410-955-7866; Fax: 410-614-0549; E-mail: dmpardol{at}welchlink.welch.jhu.edu

A.J. Adler is the recipient of an American Cancer Society Postdoctoral Fellowship and is an American Foundation For Urological Disease Research Scholar. This work was supported by a National Cancer Institute Prostate SPORE grant (CA-58236) and gifts by the Topercer family and the Telinde fund.

Gregory S. Yochum's current address is Molecular Biology Program, University of Utah, Salt Lake City, UT 84132.

Abbreviations used: BM, bone marrow; HA, hemagglutinin; NT, nontransgenic; RT, reverse transcriptase.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS